Skip to content

Ahmed Mourtada Al Qady, MD, MBBCH

NPI 1093393787ActiveIndividual· Internal Medicine· Muncie, IN

Internal Medicine (MD, MBBCH) in Muncie, Indiana, licensed in IN, with an NPI issued in April 2021. Part D covered 255 prescriptions written in 2024, 85% of them generic. Takeda Pharmaceuticals U.S.A., Inc. reported $104.49 in payments in 2025, mostly food and beverage.

Overview

NPI1093393787
StatusActive
Entity typeIndividual
CredentialMD, MBBCH
Sole proprietorNo
NPI issuedApr 1, 2021
Last updated in NPPESMay 15, 2024
Certified by providerMay 15, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Gastroenterology (FL)

Part D prescriptions in 2024

Prescriptions (claims)255 · 552 30-day fills
Patients45
Total drug cost$36,641
Generic share85% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$104.49 · 1 payment from 1 company
  • 2024$116.19 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$104.491

What the 2025 payments were for

  • Food and Beverage$104.49 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Muncie

All Internal Medicine providers in Indiana →